Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp439 | Osteoporosis: treatment | ECTS2013

The direct and indirect costs of an osteoporotic fracture: a prospective evaluation of elderly patients with a clinical fracture

Eekman Danielle , ter Wee Marieke , Coupe Veerle , Erisek-Demirtas Seher , Kramer Mark , Lems Willem

Objective: The aim of this study was to gain insight into all the current overall costs (direct medical, direct non-medical and indirect costs) of clinical fractures in osteoporotic patients aged 50 years and older in the Netherlands.Materials and methods: This prospective study was part of a larger study in which the effect of a fracture nurse on diagnosis and subsequent treatment of elderly osteoporotic patients with a recent fracture was assessed. Inc...

ba0005p463 | Other diseases of bone and mineral metabolism | ECTS2016

Change in bone mineral density with high-dose prednisone in patients with rheumatoid arthritis

Rasch Linda , van Tuyl Lilian , Kremer Martijn , Bultink Irene , Boers Maarten , Lems Willem

Background: Recently, we showed that treatment with COBRA-light therapy including prednisone with initially 30 mg/day was as effective as the original COBRA scheme, with initially 60 mg/day (Ter Wee, ARD 2015), in the treatment of rheumatoid arthritis (RA). Since high-dose glucocorticoids are associated with bone loss, we investigated the differences in bone mineral density (BMD) after 1 year of treatment in both arms.Objective: To determine whether ther...

ba0005p231 | Energy metabolism and bone, fat and bone | ECTS2016

Osteocalcin transgenic mice reveal aspects of the bone/glucose axis, as well as powerful suppression of ectopic osteocalcin protein production

Horsnell Harry , Wee Natalie , Kulkarni Rishikesh , Herzog Herbert , Baldock Paul

Rationale: Mice deficient in osteocalcin show an impaired glucose tolerance, however, the exact mechanism involved have yet to be fully elucidated. We aimed to overexpress osteocalcin to determine its effect on glucose homeostasis and explore the signalling pathway involved. We wished to expand upon previous preliminary data suggesting that this pathway involve neuropeptide Y (NPY) signalling.Objective: To analyse the in vivo and in vitro</e...

ba0001pp344 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Bone turnover markers in old old vs postmenopausal women

Inderjeeth Charles , Chan Kien , Nair Preeti , Yang Pang Wee , Chauhan Anupham , EEmun Lim

Background: Osteoporosis is not a homogenous disease. Riggs et al. identified two distinct types of osteoporosis, with different pathophysiology, patterns of bone loss and fracture types.Post-menopausal (PM) osteoporosis is triggered by withdrawal of the effect of oestrogen on bone, which leads to a sharp acceleration of bone turnover with an imbalance towards excessive osteoclastic activity. Senile osteoporosis in the old old (usually after the...

ba0003ht3 | (1) | ECTS2014

Consistent, marked and rapid increases in hip and spine BMD with the PTHrP1-34 analog, abaloparatide (BA058), compared to placebo and teriparatide

Yates John , Alexandersen Peter , Krogsaa Annesofie , Nedergaard Bettina , Clarkin Marcie , Hattersley Gary , Karsdal Morten , Christiansen Claus

Background: Treatments that result in greater increases in bone mass of normal quality by increasing bone formation rather than decreasing resorption are needed. Abaloparatide is a synthetic analog of PTHrP1-34 that has shown strong efficacy to increase bone mass and bone strength in animals. We conducted two phase 2 placebo-controlled studies both of which included abaloparatide 80 μg sc daily (ABL) in postmenopausal women with osteoporosis. Study 1 also inclu...

ba0004p95 | (1) | ICCBH2015

Osteomyelitis and septic arthritis in children: first data from the EUCLIDS network

Zenz Werner , Trobisch Andreas , Klobassa Daniela , Binder Alexander , Sperl Matthias , Martinon-Torres Federico , Rivero Irene , Carrol Enitan D , Paulus Stephane , Kalifa Bojang , Anderson Suzanne , Schlapbach Luregn , Emonts Marieke , van der Flier Michiel , de Groot Ronald , Boeddha Navin , Herberg Jethro , Agapow Paul , Levin Michael , -on behalf of EUCLIDS consortium

Background and aims: Bone and joint infections like osteomyelitis and septic arthritis occur in ~3–12/100.000 children per year in high-income countries with predominance in males. The most common causative pathogen is Staphylococcus aureus, however, only in 50% pathogen detection succeeds. The aim of this study is to describe clinical characteristics of osteomyelitis and septic arthritis in children recruited within the EUCLIDS network (<a href="http://www.eucli...

ba0005p449 | Other diseases of bone and mineral metabolism | ECTS2016

MSC injection modulates osteocyte number after high dose single limb irradiation in a murine model

Benaitreau Delphine , Wade-Gueye Marieme , Alexandre Ribault , Claire Squiban , Stephane Flamant , Radia Tamarat

Introduction: In accidental irradiations, skin, muscle and bone are altered. Mesenchymal Stem Cell (MSC) treatment has already been used for skin healing in accidental irradiations, but its effects on irradiated bone are still unknown.In this study, we characterised a mouse model of high dose local irradiation of bone and the effects of MSCs injections on osteoradionecrosis.Methods: Nude mice were locally irradiated in the left tib...

ba0003pp351 | Osteoporosis: treatment | ECTS2014

A transdermal patch delivering the PTHrP1–34 analog, abaloparatide (BA058), dose-dependently increases spine and hip bmd compared to placebo

Yates John , Alexandersen Peter , Krogsaa Annesofie , Nedergaard Bettina , Clarkin Marcie , Hattersley Gary , Hansen Kris , Karsdal Morten , Christiansen Claus

Abaloparatide (BA058) is a synthetic analog of PTHrP1–34 which greatly increases bone mass and bone strength with preservation of normal bone quality in animal models of osteoporosis. Daily s.c. abaloparatide (ABLSC) at doses of up to 80 μg daily in postmenopausal women with osteoporosis for up to 48 weeks were associated with increases in spine and femoral neck BMD of up to 12.9 and 4.1% respectively and good safety and tolerability. The increa...

ba0005p61 | Bone development/growth and fracture repair | ECTS2016

Advanced phase gestational jet lag reduces bone mass of adult offspring

van der Eerden Bram , Chaves Ines , Azimzadeh Pedram , Schreuders-Koedam Marijke , Reiss Irwin , van Leeuwen Johannes , van der Horst Gijsbertus

The mammalian circadian clock is tightly controlled by clock genes, which have been shown to regulate up to 20% of the transcriptome in any given tissue. Evidence is accumulating that light-modulation perpetually affects circadian clock performance. In accordance, shift work or chronic jet lag is associated with higher risk of disease later in life, including osteoporosis. In this study, we assessed whether gestational jet lag in mice reduces bone mass postnatally.<p class...